ALISHA WASILEWSKI: Open Payments
NPI 1134190218 · MARQUETTE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$641 in 19 payments from 14 companies in 2025. Trend: 2023 $15 · 2024 $470 · 2025 $641
Food & beverage: $641
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $184 |
| UCB, Inc. | 1 | $106 |
| EMD Serono, Inc. | 1 | $82 |
| Novartis Pharmaceuticals Corporation | 2 | $43 |
| ARGENX US, INC. | 2 | $35 |
| LivaNova USA, Inc. | 1 | $29 |
| Lundbeck LLC | 1 | $26 |
| TG Therapeutics, Inc. | 1 | $23 |
| Cala Health, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
Products named: QULIPTA, Nayzilam, Mavenclad, VYALEV, KESIMPTA, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, VYEPTI, BRIUMVI.
Industry payments across MI — which companies pay providers there.
